Damora Therapeutics, Inc. (DMRA): 10-Q filed May 12, 2026

Form type

10-Q

Filing date

May 12, 2026

Accession number

0001193125-26-219327

Filer

Damora Therapeutics, Inc. (CIK 1800315)